Chemed Corp (CHE)vsFresenius Medical Care Corporation (FMS)
CHE
Chemed Corp
$374.02
+0.03%
HEALTHCARE · Cap: $5.28B
FMS
Fresenius Medical Care Corporation
$22.03
+0.59%
HEALTHCARE · Cap: $12.47B
Smart Verdict
WallStSmart Research — data-driven comparison
Fresenius Medical Care Corporation generates 676% more annual revenue ($19.63B vs $2.53B). CHE leads profitability with a 10.5% profit margin vs 5.0%. FMS appears more attractively valued with a PEG of 0.73. FMS earns a higher WallStSmart Score of 62/100 (C+).
CHE
Buy51
out of 100
Grade: C-
FMS
Buy62
out of 100
Grade: C+
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Margin of Safety
-270.8%
Fair Value
$124.85
Current Price
$374.02
$249.17 premium
Margin of Safety
+73.4%
Fair Value
$90.32
Current Price
$22.03
$68.29 discount
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Safe zone — low bankruptcy risk
Every $100 of equity generates 25 in profit
Conservative balance sheet, low leverage
Attractively priced relative to earnings
Reasonable price relative to book value
Growing faster than its price suggests
Areas to Watch
Expensive relative to growth rate
Weak financial health signals
Revenue declined 0.1%
Earnings declined 9.1%
4.2% earnings growth
Grey zone — moderate risk
ROE of 7.9% — below average capital efficiency
5.0% margin — thin
Comparative Analysis Report
WallStSmart ResearchBull Case : CHE
The strongest argument for CHE centers on Altman Z-Score, Return on Equity, Debt/Equity.
Bull Case : FMS
The strongest argument for FMS centers on P/E Ratio, Price/Book, PEG Ratio. PEG of 0.73 suggests the stock is reasonably priced for its growth.
Bear Case : CHE
The primary concerns for CHE are PEG Ratio, Piotroski F-Score, Revenue Growth.
Bear Case : FMS
The primary concerns for FMS are EPS Growth, Altman Z-Score, Return on Equity. Thin 5.0% margins leave little buffer for downturns.
Key Dynamics to Monitor
CHE profiles as a declining stock while FMS is a value play — different risk/reward profiles.
FMS carries more volatility with a beta of 0.94 — expect wider price swings.
CHE is growing revenue faster at -0.1% — sustainability is the question.
FMS generates stronger free cash flow (564M), providing more financial flexibility.
Bottom Line
FMS scores higher overall (62/100 vs 51/100). Both earn "Buy" and "Buy" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Chemed Corp
HEALTHCARE · MEDICAL CARE FACILITIES · USA
Chemed Corporation provides hospice and hospice services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers across the United States. The company is headquartered in Cincinnati, Ohio.
Visit Website →Fresenius Medical Care Corporation
HEALTHCARE · MEDICAL CARE FACILITIES · USA
Fresenius Medical Care AG & Co. KGaA provides dialysis care and related dialysis care services in Germany, North America and internationally. The company is headquartered in Bad Homburg, Germany.
Visit Website →Compare with Other MEDICAL CARE FACILITIES Stocks
Want to dig deeper into these stocks?